649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer

• Jia Liu,
• Timothy Price,
• Mark Wong,
• Rafid Al-Asady,
• Eugene Hsu,
• Niall Tebbutt,
• Darren R Shafren,
• Naomi Croll

Affiliations

Jia Liu

2 Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiaotong University School of Medicine, Shanghai, People`s Republic of China

Timothy Price

Medical Oncology, The Queen Elizabeth Hospital and The University of Adelaide, Adelaide, South Australia, Australia

Mark Wong

Urban Studies, School of Social and Political Sciences, University of Glasgow, Glasgow, UK

Rafid Al-Asady

Department of Radiology, Westmead Hospital, Westmead, New South Wales, Australia

Eugene Hsu

Government Business Division, Elevance Health, Indianapolis, Indiana, USA

Niall Tebbutt

3Austin Hospital, Melbourne, VIC, Australia

Darren R Shafren

5Immvirx, Newcastle, NSW, Australia

Naomi Croll

5Immvirx, Newcastle, NSW, Australia